Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "ORPHAN DRUG|Designated|Treatment of pancreatic cancer" in comments (approximate match)

Showing 71 - 80 of 110 results

First page
Previous page
8
Next page
Next page

MECBOTAMAB VEDOTIN

VF40YVX65F

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

INN:mecbotamab vedotin [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/VF40YVX65F

Class:

PROTEIN

PEGVORHYALURONIDASE ALFA

P01I4980ZS

Subunit 1 (447) Similarity Search

Sequence Search

Subunit 1 (447) Similarity Search

Status:

Investigational

Source:

NCT04134468: Phase 2 Interventional Withdrawn Pancreatic Ductal Adenocarcinoma

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04134468

Class:

PROTEIN

NIDANILIMAB

ND296JF21I

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (446) Similarity Search Subunit 2 (446) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03680508: Phase 2 Interventional Active, not recruiting Adult Primary Liver Cancer

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03680508

Class:

PROTEIN

SPARTALIZUMAB

QOG25L6Z8Z

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (220) Similarity Search Subunit 4 (220) Similarity Search

Status:

Investigational

Source:

NCT04544111: Phase 2 Interventional Active, not recruiting Thyroid Cancer

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04544111

Class:

PROTEIN

SOTIGALIMAB

JEA93WJ5DG

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (215) Similarity Search Subunit 4 (215) Similarity Search

Status:

Investigational

Source:

NCT04130854: Phase 2 Interventional Active, not recruiting Locally Advanced Rectal Adenocarcinoma

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04130854

Class:

PROTEIN

PAMREVLUMAB

QS5F6VTS0O

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT03941093: Phase 3 Interventional Completed Pancreatic Cancer Non-resectable

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03941093

Class:

PROTEIN

PRITUMUMAB

Z6Q90D1G53

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (450) Similarity Search Subunit 2 (450) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

Investigational

Source:

NCT04396717: Phase 1 Interventional Completed Malignant Primary Brain Tumors

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04396717

Class:

PROTEIN

GANITUMAB

CK1441RCZ8

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (449) Similarity Search Subunit 2 (449) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

Investigational

Source:

NCT02306161: Phase 3 Interventional Active, not recruiting Metastatic Ewing Sarcoma

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02306161

Class:

PROTEIN

ENSITUXIMAB

F988K568V2

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Sequence Search

Subunit 1 (443) Similarity Search Subunit 2 (443) Similarity Search Subunit 3 (213) Similarity Search Subunit 4 (213) Similarity Search

Status:

Investigational

Source:

NCT01040000: Phase 1/Phase 2 Interventional Completed Metastatic Pancreatic Cancer

(2012)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT01040000

Class:

PROTEIN

INTERLEUKIN-12 HUMAN RECOMBINANT

02FXP10O2U

Subunit 1 (306) Similarity Search Subunit 2 (197) Similarity Search

Sequence Search

Subunit 1 (306) Similarity Search Subunit 2 (197) Similarity Search

Status:

Investigational

Source:

NCT00031733: Phase 2 Interventional Completed Intraocular Melanoma

(2002)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00031733

Class:

PROTEIN

Protein

MECBOTAMAB VEDOTIN

Protein

PEGVORHYALURONIDASE ALFA

Protein

Protein

Protein

Protein

Protein

Protein

Protein

Protein

INTERLEUKIN-12 HUMAN RECOMBINANT

Showing 71 - 80 of 110 results

First page
Previous page
8
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1